Liangfang Zhang
Overview
Explore the profile of Liangfang Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
276
Citations
14809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang D, Sun L, Shen W, Haggard A, Yu Y, Zhang J, et al.
ACS Nano
. 2024 Aug;
18(36):25069-25080.
PMID: 39190873
Neurotoxins pose significant challenges in defense and healthcare due to their disruptive effects on nervous tissues. Their extreme potency and enormous structural diversity have hindered the development of effective antidotes....
12.
Li Z, Duan Y, Zhang F, Luan H, Shen W, Yu Y, et al.
Sci Robot
. 2024 Jun;
9(91):eadl2007.
PMID: 38924422
Cytokines have been identified as key contributors to the development of inflammatory bowel disease (IBD), yet conventional treatments often prove inadequate and carry substantial side effects. Here, we present an...
13.
Krishnan N, Fang R, Zhang L
Clin Transl Med
. 2024 Jun;
14(6):e1721.
PMID: 38899759
No abstract available.
14.
Zhou Z, Mukundan N, Zhang J, Wu Y, Zhang Q, Wang D, et al.
Adv Sci (Weinh)
. 2024 Jun;
11(31):e2401423.
PMID: 38884169
Effectively neutralizing inflammatory cytokines is crucial for managing a variety of inflammatory disorders. Current techniques that target only a subset of cytokines often fall short due to the intricate nature...
15.
Zhang F, Guo Z, Li Z, Luan H, Yu Y, Zhu A, et al.
Sci Adv
. 2024 Jun;
10(24):eadn6157.
PMID: 38865468
Lung metastasis poses a formidable challenge in the realm of cancer treatment, with conventional chemotherapy often falling short due to limited targeting and low accumulation in the lungs. Here, we...
16.
Kai M, Shen W, Yu Y, Wang D, Zhang J, Wang S, et al.
Nano Lett
. 2024 Jun;
PMID: 38855905
Neurotoxins are known for their extreme lethality. However, due to their enormous diversity, effective and broad-spectrum countermeasures are lacking. This study presents a dual-modal cellular nanoparticle (CNP) formulation engineered for...
17.
Guo Z, Zhu A, Wei X, Jiang Y, Yu Y, Noh I, et al.
Bioact Mater
. 2024 May;
38:321-330.
PMID: 38764446
Given their dangerous effects on the nervous system, neurotoxins represent a significant threat to public health. Various therapeutic approaches, including chelating agents, receptor decoys, and toxin-neutralizing antibodies, have been explored....
18.
Sun L, Wang D, Feng K, Zhang J, Gao W, Zhang L
Adv Drug Deliv Rev
. 2024 Apr;
209:115320.
PMID: 38643841
The etiology of cancers is multifactorial, with certain bacteria established as contributors to carcinogenesis. As the understanding of carcinogenic bacteria deepens, interest in cancer treatment through bacterial eradication is growing....
19.
Sun L, Yu Y, Peng Y, Wang D, Wang S, Noh I, et al.
Small
. 2023 Dec;
20(18):e2308327.
PMID: 38044300
The multifaceted functions of platelets in various physiological processes have long inspired the development of therapeutic nanoparticles that mimic specific platelet features for disease treatment. Here, the development and characterization...
20.
Wang S, Wang D, Shen W, Kai M, Yu Y, Peng Y, et al.
Small
. 2023 Nov;
20(14):e2309635.
PMID: 37990378
Neurotoxins present a substantial threat to human health and security as they disrupt and damage the nervous system. Their potent and structurally diverse nature poses challenges in developing effective countermeasures....